|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Biagioni A, Skalamera I, Peri S, Schiavone
N, Cianchi F, Giommoni E, Magnelli L and Papucci L: Update on
gastric cancer treatments and gene therapies. Cancer Metast Rev.
38:537–548. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Abozeid M, Rosato A and Sommaggio R:
Immunotherapeutic strategies for gastric carcinoma: A review of
preclinical and clinical recent development. Biomed Res Int.
2017(5791262)2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Schernberg A, Rivin Del Campo E, Rousseau
B, Matzinger O, Loi M, Maingon P and Huguet F: Adjuvant
chemoradiation for gastric carcinoma: State of the art and
perspectives. Clin Transl Radiat Oncol. 10:13–22. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Song Z, Wu Y, Yang J, Yang D and Fang X:
Progress in the treatment of advanced gastric cancer. Tumour Biol.
39(1010428317714626)2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Zhang HD, Jiang LH, Sun DW, Li J and Ji
ZL: The role of miR-130a in cancer. Breast Cancer. 24:521–527.
2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen Q, Lu X and Zhang X: Noncanonical
NF-κB signaling pathway in liver diseases. J Clin Transl Hepatol.
9:81–89. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Smale ST: Hierarchies of NF-κB target-gene
regulation. Nat Immunol. 12:689–694. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer.
12(86)2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chen Z, Liu M, Liu X, Huang S, Li L, Song
B, Li H, Ren Q, Hu Z, Zhou Y and Qiao L: COX-2 regulates E-cadherin
expression through the NF-kappaB/Snail signaling pathway in gastric
cancer. Int J Mol Med. 32:93–100. 2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Koyama S: Differential expression of
intracellular apoptotic signaling molecules in tumor and
tumor-infiltrating lymphocytes during development of invasion
and/or metastasis of gastric carcinoma. Dig Dis Sci. 48:2290–2300.
2003.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yamanaka N, Sasaki N, Tasaki A, Nakashima
H, Kubo M, Morisaki T, Noshiro H, Yao T, Tsuneyoshi M, Tanaka M and
Katano M: Nuclear factor-kappaB p65 is a prognostic indicator in
gastric carcinoma. Anticancer Res. 24:1071–1075. 2004.PubMed/NCBI
|
|
13
|
Lee BL, Lee HS, Jung J, Cho SJ, Chung HY,
Kim WH, Jin YW, Kim CS and Nam SY: Nuclear factor-kappaB activation
correlates with better prognosis and Akt activation in human
gastric cancer. Clin Cancer Res. 11:2518–2525. 2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dong H, Lei J, Ding L, Wen Y, Ju H and
Zhang X: MicroRNA: Function, detection, and bioanalysis. Chem Rev.
113:6207–6233. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Su W, Mo Y, Wu F, Guo K, Li J, Luo Y, Ye
H, Guo H, Li D and Yang Z: MiR-135b reverses chemoresistance of
non-small cell lung cancer cells by downregulation of FZD1. Biomed
Pharmacother. 84:123–129. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Nezu Y, Hagiwara K, Yamamoto Y, Fujiwara
T, Matsuo K, Yoshida A, Kawai A, Saito T and Ochiya T: MiR-135b, a
key regulator of malignancy, is linked to poor prognosis in human
myxoid liposarcoma. Oncogene. 35:6177–6188. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Majeed W, Iftikhar A, Khaliq T, Aslam B,
Muzaffar H, Atta K, Mahmood A and Waris S: Gastric carcinoma:
Recent trends in diagnostic biomarkers and molecular targeted
therapies. Asian Pac J Cancer Prev. 17:3053–3060. 2016.PubMed/NCBI
|
|
18
|
Matsuoka T and Yashiro M: Biomarkers of
gastric cancer: Current topics and future perspective. World J
Gastroenterol. 24:2818–2832. 2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Bhan A, Soleimani M and Mandal SS: Long
noncoding RNA and cancer: A new paradigm. Cancer Res. 77:3965–3981.
2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Peng L, Yuan X, Jiang B, Tang Z and Li G:
lncRNAs: Key players and novel insights into cervical cancer.
Tumour Biol. 37:2779–2788. 2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li J, Meng H, Bai Y and Wang K: Regulation
of lncRNA and its role in cancer metastasis. Oncol Res. 23:205–217.
2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Dinescu S, Ignat S, Lazar AD, Constantin
C, Neagu M and Costache M: Epitranscriptomic Signatures in lncRNAs
and their possible roles in cancer. Genes (Basel).
10(52)2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ghafouri-Fard S, Abak A, Fattahi F, Hussen
BM, Bahroudi Z, Shoorei H and Taheri M: The interaction between
miRNAs/lncRNAs and nuclear factor-κB (NF-κB) in human disorders.
Biomed Pharmacother. 138(111519)2021.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Li M and Guan H: Noncoding RNAs regulating
NF-κB signaling. Adv Exp Med Biol. 927:317–336. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chen W, Li Z, Bai L and Lin Y: NF-kappaB
in lung cancer, a carcinogenesis mediator and a prevention and
therapy target. Front Biosci (Landmark Ed). 16:1172–1185.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
27
|
Li X, Zhang Z, Yu M, Li L, Du G, Xiao W
and Yang H: Involvement of miR-20a in promoting gastric cancer
progression by targeting early growth response 2 (EGR2). Int J Mol
Sci. 14:16226–16239. 2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhu M, Zhou X, Du Y, Huang Z, Zhu J, Xu J,
Cheng G, Shu Y, Liu P, Zhu W and Wang T: MiR-20a induces cisplatin
resistance of a human gastric cancer cell line via targeting CYLD.
Mol Med Rep. 14:1742–1750. 2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ma X and Ning S: Shikimic acid promotes
estrogen receptor(ER)-positive breast cancer cells proliferation
via activation of NF-κB signaling. Toxicol Lett. 312:65–71.
2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Yu J, Xie F, Bao X, Chen W and Xu Q:
MiR-300 inhibits epithelial to mesenchymal transition and
metastasis by targeting Twist in human epithelial cancer. Mol
Cancer. 13(121)2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kang Y, Zhang Y, Sun Y, Wen Y and Sun F:
MicroRNA-300 suppresses metastasis of oral squamous cell carcinoma
by inhibiting epithelial-to-mesenchymal transition. Onco Targets
Ther. 11:5657–5666. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
He FY, Liu HJ, Guo Q and Sheng JL: Reduced
miR-300 expression predicts poor prognosis in patients with
laryngeal squamous cell carcinoma. Eur Rev Med Pharmacol Sci.
21:760–764. 2017.PubMed/NCBI
|
|
33
|
Cui R, Kim T, Fassan M, Meng W, Sun HL,
Jeon YJ, Vicentini C, Tili E, Peng Y, Scarpa A, et al: MicroRNA-224
is implicated in lung cancer pathogenesis through targeting
caspase-3 and caspase-7. Oncotarget. 6:21802–21815. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
He X, Zhang Z, Li M, Li S, Ren L, Zhu H,
Xiao B and Shi R: Expression and role of oncogenic miRNA-224 in
esophageal squamous cell carcinoma. BMC Cancer.
15(575)2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Shen G, Li X, Jia YF, Piazza GA and Xi Y:
Hypoxia-regulated microRNAs in human cancer. Acta Pharmacol Sin.
34:336–341. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
He C, Wang L, Zhang J and Xu H:
Hypoxia-inducible microRNA-224 promotes the cell growth, migration
and invasion by directly targeting RASSF8 in gastric cancer. Mol
Cancer. 16(35)2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Huang Y, Yang YB, Zhang XH, Yu XL, Wang ZB
and Cheng XC: MicroRNA-21 gene and cancer. Med Oncol.
30(376)2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Shin VY, Jin H, Ng EK, Cheng AS, Chong WW,
Wong CY, Leung WK, Sung JJ and Chu KM: NF-κB targets miR-16 and
miR-21 in gastric cancer: Involvement of prostaglandin E receptors.
Carcinogenesis. 32:240–245. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Sha M, Ye J, Zhang LX, Luan ZY, Chen YB
and Huang JX: Celastrol induces apoptosis of gastric cancer cells
by miR-21 Inhibiting PI3K/Akt-NF-κB signaling pathway.
Pharmacology. 93:39–46. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ni S, Zhao L, Wang X, Wu ZH, Hua RX, Wan
CH, Zhang JY, Zhang XW, Huang MZ, Gan L, et al: CBX7 regulates stem
cell-like properties of gastric cancer cells via p16 and
AKT-NF-κB-miR-21 pathways. J Hematol Oncol. 11(17)2018.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang X, Li Y, Qi P and Ma Z: Biology of
MiR-17-92 cluster and its progress in lung cancer. Int J Med Sci.
15:1443–1448. 2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Liu F, Cheng L, Xu J, Guo F and Chen W:
MiR-17-92 functions as an oncogene and modulates NF-κB signaling by
targeting TRAF3 in MGC-803 human gastric cancer cells. Int J Oncol.
53:2241–2257. 2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yang XD and Sun SC: Targeting signaling
factors for degradation, an emerging mechanism for TRAF functions.
Immunol Rev. 266:56–71. 2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Luo Y, Wu J, Wu Q, Li X, Wu J, Zhang J,
Rong X, Rao J, Liao Y, Bin J, et al: MiR-577 regulates TGF-β
induced cancer progression through a SDPR-Modulated
positive-feedback loop with ERK-NF-κB in gastric cancer. Mol Ther.
27:1166–1182. 2019.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Li N, Zhang QY, Zou JL, Li ZW, Tian TT,
Dong B, Liu XJ, Ge S, Zhu Y, Gao J and Shen L: MiR-215 promotes
malignant progression of gastric cancer by targeting RUNX1.
Oncotarget. 7:4817–4828. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wu Y, Zhang J, Zheng Y, Ma C, Liu XE and
Sun X: MiR-216a-3p inhibits the proliferation, migration, and
invasion of human gastric cancer cells via targeting RUNX1 and
activating the NF-κB signaling pathway. Oncol Res. 26:157–171.
2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Mathis BJ, Lai Y, Qu C, Janicki JS and Cui
T: CYLD-mediated signaling and diseases. Curr Drug Targets.
16:284–294. 2015.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Xia JT, Chen LZ, Jian WH, Wang KB, Yang
YZ, He WL, He YL, Chen D and Li W: MicroRNA-362 induces cell
proliferation and apoptosis resistance in gastric cancer by
activation of NF-κB signaling. J Transl Med. 12(33)2014.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Wang YY, Ye ZY, Zhao ZS, Li L, Wang YX,
Tao HQ, Wang HJ and He XJ: Clinicopathologic significance of
miR-10b expression in gastric carcinoma. Hum Pathol. 44:1278–1285.
2013.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Chen XL, Hong LL, Wang KL, Liu X, Wang JL,
Lei L, Xu ZY, Cheng XD and Ling ZQ: Deregulation of CSMD1 targeted
by microRNA-10b drives gastric cancer progression through the NF-κB
pathway. Int J Biol Sci. 15:2075–2086. 2019.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Yang F, Xu Y, Liu C, Ma C, Zou S, Xu X,
Jia J and Liu Z: NF-κB/miR-223-3p/ARID1A axis is involved in
Helicobacter pylori CagA-induced gastric carcinogenesis and
progression. Cell Death Dis. 9(12)2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Murata M: Inflammation and cancer. Environ
Health Prev. 23(50)2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Shao L, Chen Z, Soutto M, Zhu S, Lu H,
Romero-Gallo J, Peek R, Zhang S and El-Rifai W: Helicobacter
pylori-induced miR-135b-5p promotes cisplatin resistance in
gastric cancer. FASEB J. 33:264–274. 2019.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ma J, Liu J, Wang Z, Gu X, Fan Y, Zhang W,
Xu L, Zhang J and Cai D: NF-kappaB-dependent microRNA-425
upregulation promotes gastric cancer cell growth by targeting PTEN
upon IL-1β induction. Mol Cancer. 13(40)2014.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Yang SM, Huang C, Li XF, Yu MZ, He Y and
Li J: MiR-21 confers cisplatin resistance in gastric cancer cells
by regulating PTEN. Toxicology. 306:162–168. 2013.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Wu W, Yang J, Feng X, Wang H, Ye S, Yang
P, Tan W, Wei G and Zhou Y: MicroRNA-32 (miR-32) regulates
phosphatase and tensin homologue (PTEN) expression and promotes
growth, migration, and invasion in colorectal carcinoma cells. Mol
Cancer. 12(30)2013.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Luo Z, Zheng Y and Zhang W: Pleiotropic
functions of miR107 in cancer networks. Onco Targets Ther.
11:4113–4124. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Zheng Q, Chen C, Guan H, Kang W and Yu C:
Prognostic role of microRNAs in human gastrointestinal cancer: A
systematic review and meta-analysis. Oncotarget. 8:46611–46623.
2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Li F, Liu B, Gao Y, Liu Y, Xu Y, Tong W
and Zhang A: Upregulation of MicroRNA-107 induces proliferation in
human gastric cancer cells by targeting the transcription factor
FOXO1. FEBS Lett. 588:538–544. 2014.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Zhang C, Tian W, Meng L, Qu L and Shou C:
PRL-3 promotes gastric cancer migration and invasion through a
NF-κB-HIF-1α-miR-210 axis. J Mol Med (Berl). 94:401–415.
2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Li Y, Bai W and Zhang X: Identifying
heterogeneous subtypes of gastric cancer and subtype-specific
subpaths of microRNA-target pathways. Mol Med Rep. 17:3583–3590.
2018.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Kalinowski FC, Brown RA, Ganda C, Giles
KM, Epis MR, Horsham J and Leedman PJ: MicroRNA-7: A tumor
suppressor miRNA with therapeutic potential. Int J Biochem Cell
Biol. 54:312–317. 2014.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Zhao XD, Lu YY, Guo H, Xie HH, He LJ, Shen
GF, Zhou JF, Li T, Hu SJ, Zhou L, et al: MicroRNA-7/NF-κB signaling
regulatory feedback circuit regulates gastric carcinogenesis. J
Cell Biol. 210:613–627. 2015.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Li M, Pan M, You C and Dou J: The
therapeutic potential of miR-7 in cancers. Mini Rev Med Chem.
19:1707–1716. 2019.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Ye T, Yang M, Huang D, Wang X, Xue B, Tian
N, Xu X, Bao L, Hu H, Lv T and Huang Y: MicroRNA-7 as a potential
therapeutic target for aberrant NF-κB-driven distant metastasis of
gastric cancer. J Exp Clin Canc Res. 38(55)2019.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Chen WQ, Hu L, Chen GX and Deng HX: Role
of microRNA-7 in digestive system malignancy. World J Gastrointest
Oncol. 8:121–127. 2016.PubMed/NCBI View Article : Google Scholar
|
|
67
|
Wang SM, Tie J, Wang WL, Hu SJ, Yin JP, Yi
XF, Tian ZH, Zhang XY, Li MB, Li ZS, et al: POU2F2-oriented network
promotes human gastric cancer metastasis. Gut. 65:1427–1438.
2016.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Guo Y, Zhang T, Shi Y, Zhang J, Li M, Lu
F, Zhang J, Chen X and Ding S: Helicobacter pylori inhibits
GKN1 expression via the CagA/p-ERK/AUF1 pathway. Helicobacter.
25(e12665)2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Chung Nien Chin S, O'Connor L, Scurr M,
Busada JT, Graham AN, Alipour Talesh G, Tran CP, Sarkar S, Minamoto
T, Giraud AS, et al: Coordinate expression loss of GKN1 and GKN2 in
gastric cancer via impairment of a glucocorticoid-responsive
enhancer. Am J Physiol Gastrointest Liver Physiol. 319:G175–G188.
2020.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Zhang Z, Xue H, Dong Y, Zhang J, Pan Y,
Shi L, Xiong P, Zhu J, Li W, Zheng W, et al: GKN2 promotes
oxidative stress-induced gastric cancer cell apoptosis via the
Hsc70 pathway. J Exp Clin Cancer Res. 38(338)2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Kim O, Yoon JH, Choi WS, Ashktorab H,
Smoot DT, Nam SW, Lee JY and Park WS: GKN2 contributes to the
homeostasis of gastric mucosa by inhibiting GKN1 activity. J Cell
Physiol. 229:762–771. 2014.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Crone SG, Jacobsen A, Federspiel B,
Bardram L, Krogh A, Lund AH and Friis-Hansen L: MicroRNA-146a
inhibits G protein-coupled receptor-mediated activation of NF-κB by
targeting CARD10 and COPS8 in gastric cancer. Mol Cancer.
11(71)2012.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Chen Y, Zhou B, Xu L, Fan H, Xie J and
Wang D: MicroRNA-146a promotes gastric cancer cell apoptosis by
targeting transforming growth factor β-activated kinase 1. Mol Med
Rep. 16:755–763. 2017.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Meng DF, Sun R, Liu GY, Peng LX, Zheng LS,
Xie P, Lin ST, Mei Y, Qiang YY, Li CZ, et al: S100A14 suppresses
metastasis of nasopharyngeal carcinoma by inhibition of NF-κB
signaling through degradation of IRAK1. Oncogene. 39:5307–5322.
2020.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Wee ZN, Yatim SM, Kohlbauer VK, Feng M,
Goh JY, Bao Y, Lee PL, Zhang S, Wang PP, Lim E, et al: IRAK1 is a
therapeutic target that drives breast cancer metastasis and
resistance to paclitaxel. Nat Commun. 6(8746)2015.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Diaconu S, Predescu A, Moldoveanu A, Pop
CS and Fierbinteanu-Braticevici C: Helicobacter pylori
infection: Old and new. J Med Life. 10:112–117. 2017.PubMed/NCBI
|
|
77
|
Matsushima K, Isomoto H, Inoue N, Nakayama
T, Hayashi T, Nakayama M, Nakao K, Hirayama T and Kohno S: MicroRNA
signatures in Helicobacter pylori-infected gastric mucosa.
Int J Cancer. 128:361–370. 2011.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Darnet S, Moreira FC, Hamoy IG, Burbano R,
Khayat A, Cruz A, Magalhães L, Silva A, Santos S, Demachki S, et
al: High-Throughput sequencing of miRNAs reveals a tissue signature
in gastric cancer and suggests novel potential biomarkers.
Bioinform Biol Insights. 9 (Suppl 1):1–8. 2015.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Assumpcao MB, Moreira FC, Hamoy IG,
Magalhães L, Vidal A, Pereira A, Burbano R, Khayat A, Silva A,
Santos S, et al: High-Throughput miRNA sequencing reveals a field
effect in gastric cancer and suggests an epigenetic network
mechanism. Bioinform Biol Insights. 9:111–117. 2015.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Ranjbar R, Hesari A, Ghasemi F and
Sahebkar A: Expression of microRNAs and IRAK1 pathway genes are
altered in gastric cancer patients with Helicobacter pylori
infection. J Cell Biochem. 119:7570–7576. 2018.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Li N, Wang J, Yu W, Dong K, You F, Si B,
Tang B, Zhang Y, Wang T and Qiao B: MicroRNA-146a inhibits the
inflammatory responses induced by interleukin-17A during the
infection of Helicobacter pylori. Mol Med Rep. 19:1388–1395.
2019.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Zhang W, Wang Y, Zhu Z, Zheng Y and Song
B: Propofol inhibits proliferation, migration and invasion of
gastric cancer cells by up-regulating microRNA-195. INT J Biol
Macromol. 120(Pt A):975–984. 2018.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Sui H, Lou A, Li Z and Yang J: Lidocaine
inhibits growth, migration and invasion of gastric carcinoma cells
by up-regulation of miR-145. BMC CANCER. 19(233)2019.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Xu L, Ge F, Hu Y, Yu Y, Guo K and Miao C:
Sevoflurane postconditioning attenuates hepatic
ischemia-reperfusion injury by limiting HMGB1/TLR4/NF-κB Pathway
via modulating microRNA-142 in vivo and in vitro. Front Pharmacol.
12(646307)2021.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Yang C, Gao J, Yan N, Wu B, Ren Y, Li H
and Liang J: Propofol inhibits the growth and survival of gastric
cancer cells in vitro through the upregulation of ING3.
Oncol Rep. 37:587–593. 2017.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Peng Z and Zhang Y: Propofol inhibits
proliferation and accelerates apoptosis of human gastric cancer
cells by regulation of microRNA-451 and MMP-2 expression. Genet Mol
Res 15, 2016.
|
|
87
|
Yu W, Liang X, Li X, Zhang Y, Sun Z, Liu Y
and Wang J: MicroRNA-195: A review of its role in cancers. Onco
Targets Ther. 11:7109–7123. 2018.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Qiu T, Zhou X, Wang J, Du Y, Xu J, Huang
Z, Zhu W, Shu Y and Liu P: MiR-145, miR-133a and miR-133b inhibit
proliferation, migration, invasion and cell cycle progression via
targeting transcription factor Sp1 in gastric cancer. FEBS Lett.
588:1168–1177. 2014.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Soto G, Naranjo González M and Calero F:
Intravenous lidocaine infusion. Rev Esp Anestesiol Reanim.
65:269–274. 2018.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Zhang L, Lei J, Fang ZL and Xiong JP:
MiR-128b is down-regulated in gastric cancer and negatively
regulates tumour cell viability by targeting PDK1/Akt/NF-κB axis. J
Biosci. 41:77–85. 2016.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Jiao Y, Yang H, Qian J, Gong Y, Liu H, Wu
S, Cao L and Tang L: MiR-3664-5P suppresses the proliferation and
metastasis of gastric cancer by attenuating the NF-κB signaling
pathway through targeting MTDH. Int J Oncol. 54:845–858.
2019.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Dastmalchi N, Khojasteh SMB, Nargesi MM
and Safaralizadeh R: The correlation between lncRNAs and
Helicobacter pylori in gastric cancer. Pathog Dis.
77(ftaa004)2019.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Peng WX, Koirala P and Mo YY:
lncRNA-mediated regulation of cell signaling in cancer. Oncogene.
36:5661–5667. 2017.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Gupta SC, Awasthee N, Rai V, Chava S,
Gunda V and Challagundla KB: Long non-coding RNAs and nuclear
factor-κB crosstalk in cancer and other human diseases. Biochim
Biophys Acta Rev Cancer. 1873(188316)2020.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Kong Y, Hsieh CH and Alonso LC: ANRIL: A
lncRNA at the CDKN2A/B Locus with roles in cancer and metabolic
disease. Front Endocrinol (Lausanne). 9(405)2018.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Deng W, Zhang Y, Cai J, Zhang J, Liu X,
Yin J, Bai Z, Yao H and Zhang Z: lncRNA-ANRIL promotes gastric
cancer progression by enhancing NF-κB signaling. Exp Biol Med
(Maywood). 244:953–959. 2019.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Yu X, Zheng H, Chan MT and Wu WKK: BANCR:
A cancer-related long non-coding RNA. Am J Cancer Res. 7:1779–1787.
2017.PubMed/NCBI
|
|
98
|
Zhang ZX, Liu ZQ, Jiang B, Lu XY, Ning XF,
Yuan CT and Wang AL: BRAF activated non-coding RNA (BANCR)
promoting gastric cancer cells proliferation via regulation of
NF-κB1. Biochem Bioph Res Commun. 465:225–231. 2015.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Zhang JX, Chen ZH, Chen DL, Tian XP, Wang
CY, Zhou ZW, Gao Y, Xu Y, Chen C, Zheng ZS, et al:
LINC01410-miR-532-NCF2-NF-κB feedback loop promotes gastric cancer
angiogenesis and metastasis. Oncogene. 37:2660–2675.
2018.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Zheng J, Zhang H, Ma R, Liu H and Gao P:
Long non-coding RNA KRT19P3 suppresses proliferation and metastasis
through COPS7A-mediated NF-κB pathway in gastric cancer. Oncogene.
38:7073–7088. 2019.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Mattiuzzi C and Lippi G: Current cancer
epidemiology. J Epidemiol Glob Health. 9:217–222. 2019.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Marta ZN, Agnieszka W, Jacek P, Jeleń A,
Adrian K, Dagmara SK, Sałagacka-Kubiak A and Balcerczak E: NFKB2
gene expression in patients with peptic ulcer diseases and gastric
cancer. Mol Biol Rep. 47:2015–2021. 2020.PubMed/NCBI View Article : Google Scholar
|
